Examining risk of suicide and use of ACE inhibitors, ARBs

What The Study Did:

Associations between risk of suicide and medications widely used in the management of high blood pressure, chronic kidney disease, heart failure and diabetes (angiotensin-converting enzyme inhibitors and angiotensin receptor blockers) were examined in this observational study.

To access the embargoed study:

Visit our For The Media website at this link

https:/

/

media.

jamanetwork.

com/

Authors:

Tony Antoniou, Pharm.D., Ph.D., of St. Michael’s Hospital in Toronto, is the corresponding author.

(doi:10.1001/jamanetworkopen.2019.13304)

Editor’s Note:

The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

###

Media advisory:

The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article

This link will be live at the embargo time:

http://jamanetwork.

com/

journals/

jamanetworkopen/

fullarticle/

10.

1001/

jamanetworkopen.

2019.

13304?utm_source=

For_The_Media&utm_medium=

referral&utm_campaign=

ftm_links&utm_term=

101619

About JAMA Network Open:

JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. Every Wednesday and Friday, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.